Researcher.Life Logo

European Heart Journal - Cardiovascular Pharmacotherapy : Impact Factor & More

eISSN: 2055-6845pISSN: 2055-6837

Key Metrics

CiteScore
7.8
H-Index
35
Impact Factor
5 - 10
SJR
Q1Pharmacology (medical)
SNIP
1.61
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Heart Journal - Cardiovascular Pharmacotherapy

European Heart Journal - Cardiovascular Pharmacotherapy Journal Specifications

Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Heart Journal - Cardiovascular Pharmacotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Heart Journal - Cardiovascular Pharmacotherapy

Why does research integrity affect us all?
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Why does research integrity affect us all?
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
  • 19 May 2026
  • European heart journal. Cardiovascular pharmacotherapy

FAQs on European Heart Journal - Cardiovascular Pharmacotherapy